Evidence map›Paper›PMID 28398221›Full record

ArticleBiomolecules2017

Amyloid Fibrils from Hemoglobin.

Nadishka Jayawardena, Manmeet Kaur, Smitha Nair, Jenny Malmstrom, David Goldstone, Leonardo Negron, Juliet A Gerrard, Laura J Domigan

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Secondary Structure in Amyloids in Relation to Their Wild Type Forms.International journal of molecular sciences · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nadishka JayawardenaSchool of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand. gjay797@aucklanduni.ac.nz.
Manmeet KaurSchool of Biological Sciences, University of Canterbury, Christchurch 8041, New Zealand. manmeet.kaur@hi-aspect.com.
Smitha NairSchool of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand. s.tipparaju@auckland.ac.nz.
Jenny MalmstromDepartment of Chemical and Materials Engineering, The University of Auckland, Auckland 1010, New Zealand. j.malmstrom@auckland.ac.nz.
David GoldstoneSchool of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand. d.goldstone@auckland.ac.nz.
Leonardo NegronCallaghan Innovation, Lower Hutt 5010, New Zealand. leonardo.negron@callaghaninnovation.govt.nz.
Juliet A GerrardSchool of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand. j.gerrard@auckland.ac.nz.
Laura J DomiganSchool of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand. l.domigan@auckland.ac.nz.
University of Auckland · NZCallaghan Innovation · NZUniversity of Canterbury · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid fibrils are a class of insoluble protein nanofibers that are formed via the self-assembly of a wide range of peptides and proteins. They are increasingly exploited for a broad range of applications in bionanotechnology, such as biosensing and drug delivery, as nanowires, hydrogels, and thin films. Amyloid fibrils have been prepared from many proteins, but there has been no definitive characterization of amyloid fibrils from hemoglobin to date. Here, nanofiber formation was carried out under denaturing conditions using solutions of apo-hemoglobin extracted from bovine waste blood. A characteristic amyloid fibril morphology was confirmed by transmission electron microscopy (TEM) and atomic force microscopy (AFM), with mean fibril dimensions of approximately 5 nm diameter and up to several microns in length. The thioflavin T assay confirmed the presence of β-sheet structures in apo-hemoglobin fibrils, and X-ray fiber diffraction showed the characteristic amyloid cross-β quaternary structure. Apo-hemoglobin nanofibers demonstrated high stability over a range of temperatures (-20 to 80 °C) and pHs (2-10), and were stable in the presence of organic solvents and trypsin, confirming their potential as nanomaterials with versatile applications. This study conclusively demonstrates the formation of amyloid fibrils from hemoglobin for the first time, and also introduces a cost-effective method for amyloid fibril manufacture using meat industry by-products.

Indexed as

Protein MultimerizationAmyloidAnimalsCattleHemoglobinsHydrogen-Ion ConcentrationPeptide HydrolasesProtein Structure, SecondarySolubilitySolventsTemperatureAmyloidHemoglobinsPeptide HydrolasesSolventsamyloid fibrilshemoglobinnanofibernanofibril

Identifiers

PMID28398221
PMCPMC5485726
OpenAlexW2606161470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.